- Global Pharma News & Resources

The Global ELISpot and FluoroSpot Assay Market by Product, Application and End-user - Forecast to 2023, Expecting to Reach $287 Million -

The "ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer, Ancillary Products), Application (Transplant, Vaccines, Clinical Trials, Cancer), End User (Hospital, Labs, Research Institute) - Global Forecast to 2023" report has been added to's offering. The ELISpot and FluoroSpot market is projected to reach USD 287 million by 2023 from USD 135 million in 2018, at a CAGR of 16.2% during the forecast period. The rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers, are factors expected to drive market growth during the forecast period. The use of FluoroSpot assays for multiple-analyte detection in a single well is also expected to provide opportunities for the growth of the market.

By product, in 2018, the assay kits segment is expected to account for the largest market share. This segment is also expected to grow at the highest CAGR during the forecast period. The rising incidence of chronic diseases and technological advancements are driving the growth of this product segment.

On the basis of application, in 2018, the diagnostics segment is expected to account for the larger share of the ELISpot and FluoroSpot market. The large share of this segment can be attributed to the rising global prevalence of infectious diseases and the increasing use of ELISpot kits for disease diagnosis.

Market Dynamics


  • Rising Global Incidence of Chronic Diseases
  • Increasing Vaccine Development to Address the Challenge of Antimicrobial Resistance
  • Technological Advancements in ELISpot and FluoroSpot Assay Kits and Analyzers


  • Use of FluoroSpot Assays for Multiple-Analyte Detection in a Single Well


  • Availability of Alternative Detection Technologies

Key Topics Covered

1 Introduction 2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 ELISpot and FluoroSpot Market, By Product

7 ELISpot and FluoroSpot Market, By Application

8 ELISpot and FluoroSpot Market, By End User

9 ELISpot and FluoroSpot Market, By Region

10 Competitive Landscape

11 Company Profiles

  • Abcam
  • Autoimmun Diagnostika GmbH
  • Becton, Dickinson and Company
  • Bio-Techne
  • Biotech Investissement Group
  • Cellular Technology Limited (CTL)
  • Lophius Biosciences GmbH
  • Mabtech AB
  • Oxford Immunotec
  • U-Cytech Biosciences

For more information about this report visit

View source version on

Editor Details

Last Updated: 13-Dec-2018